C07D 235 - Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings

Patents for C07D 235 - Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings (15,325)
12/2011
12/15/2011	US20110306611 Transcription factor modulating compounds and methods of use thereof
12/14/2011	CN102282129A 用于治疗癌症和免疫和自身免疫疾病的细胞程序死亡诱导药剂 Procedures for the treatment of cancer and cellular immune and autoimmune diseases inducing agent
12/14/2011	CN102281877A 苯达莫司汀游离碱的新颖形式 New forms of bendamustine free base
12/14/2011	CN102276585A 4-取代-苯联芳基-羧酸酯类衍生物的制备方法及其医药用途 4-substituted - phenyl biaryl - carboxylic acid ester derivatives of preparation and pharmaceutical use
12/14/2011	CN102276534A 6-（n-酰基）胺基苯并咪唑类化合物及其制备方法和用途 6- (n- acyl) amino benzimidazole compound and preparation method and use
12/14/2011	CN101490014B 苯并咪唑和氮杂苯并咪唑的区域选择性钯催化合成 Selective palladium-catalyzed synthesis of benzimidazole and aza region benzimidazole
12/14/2011	CN101365685B 2-(苯并咪唑-1-基)-乙酰胺联芳基衍生物及它们作为trpv1受体抑制剂的用途 2- (benzimidazol-1-yl) - acetamide biaryl derivatives and their use as inhibitors of receptor trpv1
12/13/2011	US8076367 Benzimidazolylidene propane-1,3-dione derivative or salt thereof
12/13/2011	US8076366 Forms of bendamustine free base
12/13/2011	US8076365 Viral polymerase inhibitors
12/13/2011	US8076324 Di(hetero)arylcyclohexane derivatives, their preparation, their use and pharmaceutical compositions comprising them
12/13/2011	CA2496139C Benzimidazole derivatives
12/13/2011	CA2494628C Acylated arylcycloalkylamines and their use as pharmaceuticals
12/08/2011	WO2011120912A9 Fungicidal iminoderivatives
12/08/2011	US20110301192 Inhibitors of Cyclin Kinase Inhibitor p21
12/08/2011	US20110301156 Vanilloid Receptor Ligands, Pharmaceutical Compositions Containing Them, Process For Making Them, and Use Thereof to Treat Pain and Other Conditions
12/08/2011	US20110301146 Glycogen synthase kinase-3 beta inhibitors containing 7-hydroxy-benzoimidazole-4-yl-methanone derivatives
12/07/2011	CN102272971A 发光元件材料和发光元件 Emitting element material and the light emitting element
12/07/2011	CN102272106A 用于体内和体外成像的单官能羰花青染料 Monofunctional carbocyanine dyes for in vivo and in vitro imaging
12/07/2011	CN102267949A 替米沙坦制备新工艺 Telmisartan preparation of new technology
12/07/2011	CN102267948A 芴并二咪唑衍生物及其制备方法 Fluorene and two imidazole derivatives and its preparation method
12/07/2011	CN102267924A 抗菌剂 Antibacterial agents
12/07/2011	CN101781256B 一种4-甲基-2-丙基-1h-苯并咪唑-6-甲酰胺类化合物的制备方法 Of 4-methyl-2-benzimidazole-6-propyl--1h- preparation of carboxamides
12/07/2011	CN101389610B 作为香草素受体1(vr1)抑制剂的新苯并咪唑衍生物 As vanilloid receptor 1 (vr1) inhibitors new benzimidazole derivatives
12/06/2011	US8071650 Vanilloid receptor modulators; analgesic, antiinflammatory and antiulcer effects; such as 1-(1H-indol-5-ylmethyl)-3-phenethylthiourea
12/06/2011	CA2615019C Hiv reverse transcriptase inhibitors
12/06/2011	CA2600570C Benzazole derivatives, compositions, and methods of use as .beta.-secretase inhibitors
12/06/2011	CA2491243C Viral inhibitors
12/01/2011	WO2011148956A1 Fused imidazole derivative
12/01/2011	US20110294804 Novel bicyclic heterocyclic compound
12/01/2011	CA2800521A1 Fused imidazole derivative
11/2011
11/30/2011	EP2390249A2 Novel cycloalkene derivatives and organic electronic devices using the same
11/30/2011	EP2389375A2 Hydroxamic acid derivatives
11/30/2011	EP1613368B1 Carboxamide spirohydantoin cgrp receptor antagonists
11/30/2011	CN102264707A 新型双环型杂环化合物 Novel bicyclic heterocyclic compounds
11/30/2011	CN102260223A 偕二氟亚甲基串联的含1,3-苯并二唑化合物及其合成方法 1,3-oxadiazole-containing compounds and synthetic kai difluoromethylene series
11/29/2011	US8067614 N-substituted (benzoimidazol-2-yl)phenylamines, processes for their preparation, their use as a medicament or diagnostic aid, and a medicament comprising them
11/29/2011	US8067454 Thio-substituted Anthra [1, 2-d] imidazole- 6, 11-dione derivatives, preparation method and application thereof
11/29/2011	US8067418 Tricyclic angiotensin II agonists
11/29/2011	US8067415 Compounds useful as antagonists of CCR2
11/29/2011	CA2522535C Chemokine receptor binding heterocyclic compounds with enhanced efficacy
11/29/2011	CA2494302C Acylated, heteroaryl-condensed cycloalkenylamines and their use as pharmaceuticals
11/24/2011	WO2011146300A1 Novel prolylcarboxypeptidase inhibitors
11/24/2011	WO2011079193A3 Preparation of bendamustine and its salts
11/24/2011	US20110288292 Materials for organic electroluminescence devices
11/24/2011	US20110288139 Substituted amino-benzimidazoles, medicaments comprimising said compound, their use and their method of manufacture
11/23/2011	EP2388263A1 Imidazo[2,1-b]thiazole derivatives as sirtuin modulators
11/23/2011	EP2387560A2 Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
11/23/2011	EP2387400A1 Novel forms of bendamustine free base
11/23/2011	EP1391451B1 2-iminopyrrolidine derivates
11/23/2011	CN102256944A Sphingosine-1-phosphate receptor antagonists
11/23/2011	CN102250021A Method for preparing quinoxaline compounds and benzimidazole compounds
11/23/2011	CN102250013A Preparation method of albendazole
11/23/2011	CN102250012A Process for preparing benzimidazole insectifuge oxibendazole
11/23/2011	CN102249958A Inhibitor of benzoylammonia histone deacetylase
11/23/2011	CN101914063B N, N'-di-[3- hydroxyl-4-(2- benzimidazole) phenyl] urea and application thereof as zinc ion fluorescent probe
11/22/2011	US8063089 Inhibit the multimerization of nucleophosmin; cancer
11/22/2011	US8063053 1-(arylsulfonyl)-4-(piperazin-1-yl)-1H-benzimidazoles as 5-hydroxytryptamine-6 ligands
11/17/2011	US20110282072 Self-assembled nanostructures
11/17/2011	US20110282066 Screening method for substance useful as agent for treating prostate cancer
11/17/2011	US20110281879 Sulfonyl containing compounds as cysteine protease inhibitors
11/16/2011	CN102241635A Preparation method for anthelmintic benzimidazole fenbendazole
11/16/2011	CN101863840B Preparation method of 5-amino-6-methyl benzimidazolone
11/15/2011	USRE42931 Covalent tethering of functional groups to proteins
11/15/2011	US8058450 Nitrogenous heterocyclic derivative and organic electroluminescence device making use of the same
11/15/2011	CA2401441C Indane derivatives
11/10/2011	WO2011138657A1 Aryl substituted olefinic compounds as pde10a inhibitors
11/10/2011	WO2011071314A3 Processes for preparing crystalline forms a and b of ilaprazole and process for converting the crystalline forms
11/10/2011	US20110275663 N-Acylthiourea and N-Acylurea Inhibitors of the Hedgehog Protein Signalling Pathway
11/10/2011	US20110275630 Isoindolinone kinase inhibitors
11/09/2011	EP2385039A1 2-Iminoisoindolinone derivatives as thrombin receptor antagonists
11/08/2011	US8053450 P2Y1 Purinoreceptor; thromboembolic disorders; compounds are 2-((hetero)arylamino) benzimidazoles, benzoxazoles or benzothiazoles such as [2-(2-tert-butyl-phenoxy)-pyridin-3-yl]-(6-methyl-1H-benzoimidazol-2-yl)-amine
11/08/2011	US8053445 Utilities of olefin derivatives
11/08/2011	CA2499639C Imidazopyridines as cyclin dependent kinase inhibitors
11/08/2011	CA2476054C Pharmaceutical composition for the oral administration of 3-[(2-{[4-(hexyloxycarbonylamino-imino-methyl)-phenylamino)-methyl}-1-methyl-1h-benzimidazol-5-carbonyl)-pyridin-2-yl-amino)-propionic acid ethyl ester and the salts thereof
11/03/2011	WO2011136484A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same
11/03/2011	WO2011136264A1 [5,6] heterocyclic compound
11/03/2011	US20110269806 2-(2-hydroxybiphenyl-3-yl)-1h-benzoimidazole-5-carboxamidine derivatives as factor viia inhibitors
11/03/2011	US20110269736 1,1'-Diadamantyl carboxylic acids, medicaments containing such compounds and their use
11/03/2011	US20110269706 Hydroxamic Acid Derivatives
11/03/2011	CA2791020A1 [5,6] heterocyclic compound
11/02/2011	EP2383813A1 Light-emitting element material and light-emitting element
11/02/2011	EP1399416B1 Peptide deformylase inhibitors
11/02/2011	CN102229570A New method for synthesizing telmisartan intermediates
11/02/2011	CN102229569A Method for preparing Br[phi]nsted acidic ionic liquid based on benzimidazole cations
11/02/2011	CN102229568A Preparation and use for phenyl ether-bridged N-heterocyclic carbene metal complex
11/01/2011	CA2645257C Sulfonyl benzimidazole derivatives
11/01/2011	CA2535749C Ppar activating compound and pharmaceutical composition containing same
11/01/2011	CA2479012C Broadspectrum substituted benzimidazole sulfonamide hiv protease inhibitors
10/2011
10/27/2011	WO2011133661A2 Methods and compositions related to dopaminergic neuronal cells
10/27/2011	WO2011132712A1 Novel hydroxamic acid derivative
10/27/2011	US20110263667 Salts of isobutyric acid (1 r,2r,4r*) -2- (2- - ethyl)-5-phenyl-bicyclo [2.2.2] oct-5-en-2-yl
10/27/2011	US20110263648 Bridged tetrahydronaphthalene derivatives
10/27/2011	US20110263566 7-Hydroxy-benzoimidazole-4-yl-methanone Derivatives and PBK Inhibitors Containing the Same
10/27/2011	US20110262388 Novel inhibitors
10/27/2011	CA2796616A1 Methods and compositions related to dopaminergic neuronal cells
10/26/2011	EP2380885A1 Guanidine compounds and use of same as binding partners for 5-HT5 receptors
10/26/2011	EP2380881A1 Novel bicyclic heterocyclic compound
10/26/2011	EP1756112B1 Pyrrolobenzimidazolones and their use as antiproliferative agents
10/26/2011	CN102227411A Antibacterial compounds

1 ... 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 ... 154